Skip to main content
Premium Trial:

Request an Annual Quote

New Products: New Antibody Technology from Morphosys and More

Premium

Morphosys this week presented its new antibody technology Ylanthia, the next generation of the company’s HuCAL platform.

According to the company, Ylanthia is the industry’s largest fragment antigen binding library, comprising more than 100 billion distinct human antibodies, with all antibodies pre-selected for expression levels, stability, and aggregation behavior. The company optimizes the Ylanthia library with its Slonomics technology, which, it said, offers improved speed and flexibility compared to its HuCAL line.


Gentel this week launched its new Colony Surveillance Assays for monitoring specific pathogen-free status in nonhuman primates.

The panel uses Gentel’s Proteomics Multi-System and tests for 11 infectious agents including rhesus rhadinovirus and spumavirus simian foamy virus.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.